GEMCITABINE ELAIDATE
UNII 231C73W7LG

Substance Identification & Data

This profile provides standardized clinical and technical data for Gemcitabine Elaidate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 231C73W7LG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 210829-30-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

231C73W7LG

CAS Registry Number

210829-30-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GEMCITABINE ELAIDATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H43F2N3O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HESSNRGIEVBPRB-QDDPNBLJSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C79803

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9828310

Unique identification number in the NCBI database of chemical substances.

INN ID

9409

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-13

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O(C[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)C(=O)CCCCCCC/C=C/CCCCCCCC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gemcitabine Elaidate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.